Advertisements


Retailers sue Allergan over dry-eye drug

Allergan Inc was sued on Wednesday by four large U.S. retailers that accused the drugmaker of antitrust violations for trying to stop rivals from selling generic versions of Restasis, its medication to treat dry-eye disease......»»

Category: topSource: moneycentralMay 16th, 2018

Walgreen, Kroger, Albertsons, HEB sue Allergan over dry-eye drug

NEW YORK (Reuters) - Allergan Inc was sued on Wednesday by four large U.S. retailers that accused the drugmaker of antitrust violations for trying to stop rivals from selling generic versions of Restasis, its medication to treat dry-eye disease......»»

Category: topSource: reutersMay 16th, 2018

Aclaris completes $65M deal for rosacea treatment

Malvern-based Aclaris Therapeutics Inc. completed its previously announced $65 million acquisition of Rhofade, a rosacea treatment, from Allergan. The Food and Drug Administration approved Rhofade, a cream, last year as topical treatment of persis.....»»

Category: topSource: bizjournalsDec 3rd, 2018

FDA Panel Rejection Of Alkermes Depression Drug Is Good News For Allergan

FDA Panel Rejection Of Alkermes Depression Drug Is Good News For Allergan.....»»

Category: topSource: seekingalphaNov 6th, 2018

Drug stocks are "no longer" reliable safety nets for investors: Cramer

Jim Cramer issues a warning to investors about the pharmaceutical sector, which includes high-profile stocks like Allergan and Gilead......»»

Category: topSource: madmoneyNov 1st, 2018

Allergan plans to file for U.S. approval of new migraine drug by Q1 of 2019

Allergan PLC said early Wednesday .....»»

Category: topSource: marketwatchOct 17th, 2018

FDA issues warnings, fines to area retailers over sale of e-cigs to youths

The Food and Drug Administration took action against 16 area retail locations as part of a sting on the sale of e-cigarettes to minors. The FDA issued more than 1,300 warning letters and fines as part of what it called the largest coordinated enforcem.....»»

Category: topSource: bizjournalsOct 8th, 2018

Allergan Eyes Vraylar Label Expansion, FDA Accepts sNDA

FDA accepts Allergan's (AGN) sNDA for label expansion of its schizophrenia drug, Vraylar (cariprazine) to include.....»»

Category: dealsSource: nytSep 27th, 2018

How to find out when stores are reopening from Florence - USA TODAY

USA TODAYHow to find out when stores are reopening from FlorenceUSA TODAYWhile hundreds of grocery stores, drug stores and other retailers in the Carolinas remained closed Saturday because of Tropcial Storm F.....»»

Category: topSource: googlenewsSep 16th, 2018

FDA Cracks Down on Juul and E-Cigarette Retailers - New York Times

New York TimesFDA Cracks Down on Juul and E-Cigarette RetailersNew York TimesWASHINGTON — The Food and Drug Administration on .....»»

Category: topSource: googlenewsSep 12th, 2018

Vitaliy Katsenelson"s Contrarian Edge: Investors have misdiagnosed Amazon’s push into the pharmacy business

Walgreens and other established drug retailers can handle Amazon’s threat, writes Vitaliy Katsenelson......»»

Category: topSource: marketwatchAug 20th, 2018

Allergan/Tobira And Cenicriviroc: The Overlooked And Misunderstood Immune Modulatory Anti-NASH Drug Candidate

Allergan/Tobira And Cenicriviroc: The Overlooked And Misunderstood Immune Modulatory Anti-NASH Drug Candidate.....»»

Category: topSource: seekingalphaJul 6th, 2018

Amazon to buy PillPack

Amazon said it's buying online pharmacy PillPack, sending shares of drug distributors and retailers tumbling. Fred Katayama reports......»»

Category: videoSource: reutersJun 28th, 2018

Amazon"s foray into online pharmacy could be a "game changer", says Phil Bak

Exponential ETF's CEO tells Reuters' Fred Katayama why drug retailers and distributors should be concerned by Amazon's purchase of PillPack. He also comments on BJ's Wholesale Club's splashy IPO......»»

Category: videoSource: reutersJun 28th, 2018

Amazon to buy PillPack in drug retailing push

(Reuters) - Amazon.com Inc said on Thursday it would buy online pharmacy PillPack, a small but significant step into the U.S. healthcare sector, sending shares of drug distributors and retailers lower......»»

Category: topSource: reutersJun 28th, 2018

Why Retailers Are Installing Blue Lights In Bathrooms to Discourage Drug Use

Convenience stores are experimenting with blue lights in bathrooms to deter drug use As the nation grapples with the harrowing effec.....»»

Category: europeSource: fortuneJun 25th, 2018

Stores install blue lights in restrooms to deter drug use

Retailers are installing blue light bulbs in public .....»»

Category: topSource: usatodayJun 25th, 2018

Retailers testing blue lights to ward off drug users

Retailers are experimenting with blue lights to discourage people from using drugs in store bathrooms by making it tougher for them to see their veins when injecting. .....»»

Category: topSource: usatodayJun 25th, 2018

Retailers experiment with blue lights to deter drug use

Colored bulbs cast an eerie blue glow in the restroom of a convenience store where people who inject heroin and other drugs have been seeking the relative privacy of the stalls to shoot up......»»

Category: topSource: washpostJun 24th, 2018

Alder slips after Allergan releases data from migraine drug study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 11th, 2018

This pot retailer has a $1.6B valuation and, coming soon, Canadian stock

They used to be drug dealers. Then they became dispensaries. Now we have cannabis retailers that "seek to replicate the Apple store model" and give customers "a comfortable, informative and nonthreatening environment.".....»»

Category: topSource: moneycentralMay 26th, 2018